Navigation Links
Qforma Appoints Two New Executives
Date:3/11/2011

SANTA FE, N.M., March 11, 2011 /PRNewswire/ -- Qforma, an advanced analytics and predictive modeling company, today announced the appointments of Elna Hamp to Vice President, Business Development and Joann Flynn to Marketing Manager.

"As our clients' business models continue to evolve with the changing healthcare landscape, expertise across multiple disciplines is important to Qforma," said Al Reicheg, Chief Commercial Officer of Qforma. "Our clients will benefit from Elna's 23-plus years of payer and provider experience as well as sales, marketing and account management expertise, and Joann's unique dual background in the pharmaceutical and wellness industries."

Elna Hamp was formerly Vice President of Sales and Marketing for Verisys Corporation. Previously, she worked for Contexo Media, which was acquired by Access Intelligence LLC and Ingenix, Inc., a subsidiary of UnitedHealth Group. Elna was a recipient of the Lifetime Achievement Award for her valuable and long-term contribution to Ingenix. She earned a Bachelor of Arts degree in Marketing from Utah State University.

During the past 15 years, Joann Flynn has held various management positions at such companies as inVentiv Health, Publicis and Vox Medica. Most recently, she ran her own nutrition consulting company, Designs for Wellness LLC. Joann holds a Bachelor of Science degree from the University of Delaware and a Master of Science degree from the University of Bridgeport, CT.

About QformaQforma is the leading provider of advanced analytics and predictive modeling for the health sciences industry. The company leverages the talents of health sciences executives, physicists, mathematicians and programmers, to deliver actionable insights from large disparate data.  Qforma provides powerful sales, marketing and managed care contracting tools, including physician social network solutions, to help its clients realize significant resource efficiencies. Qforma's innovative technologies were first developed at the world-renowned Los Alamos National Laboratory.Media Contacts: Lisa Haley, Qforma(505) 603-7596lhaley@qforma.comJeff Hoyak, MCS Healthcare Public Relations(800) 477-9626, ext. 312jeffh@mcspr.com
'/>"/>

SOURCE Qforma
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Qforma Appoints Erin McLaughlin as Director, Field Operations
2. Qforma, Leading Provider of Healthcare Analytics, Announces Three New Appointments
3. Quark Pharmaceuticals Appoints New Chief Medical Officer
4. West Pharmaceutical Services, Inc. Appoints New Director
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. Curemark Appoints Preeminent Pediatrics Gastroenterologist
7. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
10. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
11. NovaRx Appoints Industry Veteran as President and COO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Dec. 6, 2016 Eurofins Genomics today ... the College of American Pathologists (CAP) and certification ... its new laboratory in Louisville, KY ... North American headquarters. "Our new CLIA-licensed ... which is still considered the ,Gold Standard, method ...
(Date:12/6/2016)... WESTLAKE VILLAGE, Calif. , Dec. 6, ... a privately held, clinical-stage medical dermatology and ... Creabilis plc, a privately held specialty pharmaceutical ... for common inflammatory skin conditions, including psoriasis, ... terms of the agreement, Sienna will make ...
(Date:12/6/2016)... 2016  Regulus Therapeutics Inc. (NASDAQ: ... and development of innovative medicines targeting microRNAs, today ... R&D day, held in New York ... anti-miR targeting microRNA-27 (miR-27) for the treatment of ... anti-miR targeting microRNA-17 (miR-17) for the treatment of ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... Gensuite ... Brilliance Awards under the Best New Product Launch category. Gensuite’s entry on their ... experience. , BOC Global Events & Training Group is a professional event and ...
(Date:12/7/2016)... ... December 07, 2016 , ... “The Road To Restoration”: an ... not a one hour a week showing of hands. “The Road To Restoration” is ... “Perhaps you are familiar with the brass ring that you could reach out for, ...
(Date:12/7/2016)... , ... December 07, 2016 , ... “Fred Rides a ... Christmas Day that follows. , “Fred Rides a Train” is the creation of ... short stories since her teen years in Michigan. The "Fred, the Dog" series is ...
(Date:12/7/2016)... ... 2016 , ... Dr. Greg Leyer, the Chief Scientific Officer ... DC workshop on November 2nd. The conference was an opportunity for both probiotic ... regulations. , Dr. Leyer spoke about two main topics at the IPA ...
(Date:12/6/2016)... ... 06, 2016 , ... People with Parkinson’s disease and cognitive ... type of MRI, according to a study appearing online in the journal Radiology. ... characterized by tremors or trembling and stiffness in the limbs, impaired balance and ...
Breaking Medicine News(10 mins):